难治性呼吸困难的管理：普通内科医生的综述。
Management of Refractory Breathlessness: a Review for General Internists.
机构信息
Division of Hospital Medicine, Emory University School of Medicine, Atlanta, GA, USA.
, Atlanta, USA.
出版信息
J Gen Intern Med. 2021 Apr;36(4):1035-1040. doi: 10.1007/s11606-020-06439-0. Epub 2021 Jan 19.
Abstract
Internists frequently care for patients who suffer from breathlessness in both the inpatient and the outpatient settings. Patients may experience chronic refractory breathlessness despite thorough evaluation and management of their underlying medical illnesses. Left unmanaged, chronic breathlessness is associated with worsened quality of life, more frequent visits to the emergency room, and decreased activity levels, as well as increased levels of depression and anxiety. This narrative review summarizes recent research on interventions for the relief of breathlessness, including both non-pharmacologic and pharmacologic options.
摘要
内科医生经常在住院和门诊环境中照顾患有呼吸困难的患者。尽管对患者的基础疾病进行了彻底的评估和管理，但他们仍可能会持续存在难治性呼吸困难。如果不加以管理，慢性呼吸困难会导致生活质量下降、急诊就诊次数增加、活动水平降低，以及抑郁和焦虑程度增加。本综述总结了近期关于缓解呼吸困难干预措施的研究，包括非药物和药物治疗选择。
相似文献
1
Management of Refractory Breathlessness: a Review for General Internists.难治性呼吸困难的管理：普通内科医生的综述。
J Gen Intern Med. 2021 Apr;36(4):1035-1040. doi: 10.1007/s11606-020-06439-0. Epub 2021 Jan 19.
2
The active identification and management of chronic refractory breathlessness is a human right.积极识别和管理慢性难治性呼吸困难是一项人权。
Thorax. 2014 Apr;69(4):393-4. doi: 10.1136/thoraxjnl-2013-204701. Epub 2013 Nov 8.
3
Management of acute breathlessness in the person with chronic refractory breathlessness.慢性难治性呼吸困难患者急性呼吸困难的管理
Curr Opin Support Palliat Care. 2015 Sep;9(3):212-6. doi: 10.1097/SPC.0000000000000153.
4
Prevalence and management of chronic breathlessness in COPD in a tertiary care center.在一家三级护理中心慢性阻塞性肺疾病慢性呼吸困难的患病率和管理。
BMC Pulm Med. 2019 May 16;19(1):95. doi: 10.1186/s12890-019-0851-5.
5
Individualized breathlessness interventions may improve outcomes in patients with advanced COPD.个体化呼吸困难干预措施可能改善晚期 COPD 患者的结局。
Respirology. 2018 Dec;23(12):1146-1151. doi: 10.1111/resp.13324. Epub 2018 May 15.
6
Prevalence and assessment of breathlessness in the clinical setting.呼吸困难在临床环境中的流行情况和评估。
Expert Rev Respir Med. 2014 Apr;8(2):151-61. doi: 10.1586/17476348.2014.879530. Epub 2014 Jan 22.
7
Identification and Assessment of Breathlessness in Clinical Practice: A Systematic Review and Narrative Synthesis.临床实践中呼吸困难的识别和评估：系统评价和叙述性综合。
J Pain Symptom Manage. 2020 Mar;59(3):724-733.e19. doi: 10.1016/j.jpainsymman.2019.10.014. Epub 2019 Oct 23.
8
The role of airflow for the relief of chronic refractory breathlessness.气流对缓解慢性难治性呼吸困难的作用。
Curr Opin Support Palliat Care. 2015 Sep;9(3):206-11. doi: 10.1097/SPC.0000000000000160.
9
Low-intensity educational interventions supporting self-management to improve outcomes related to chronic breathlessness: a systematic review.支持自我管理以改善与慢性呼吸困难相关结局的低强度教育干预措施：系统评价。
NPJ Prim Care Respir Med. 2019 Nov 29;29(1):41. doi: 10.1038/s41533-019-0152-8.
10
Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial.缓解难治性呼吸困难患者呼吸困难：姑息性氧与空气双盲、随机对照试验。
Lancet. 2010 Sep 4;376(9743):784-93. doi: 10.1016/S0140-6736(10)61115-4.
引用本文的文献
1
Pathophysiology and clinical evaluation of the patient with unexplained persistent dyspnea.不明原因持续性呼吸困难患者的病理生理学和临床评估。
Expert Rev Respir Med. 2022 May;16(5):511-518. doi: 10.1080/17476348.2022.2030222. Epub 2022 Jan 20.
2
Reliability, Validity, and Responsiveness of the DEG, a Three-Item Dyspnea Measure.三项式呼吸困难测量指标DEG的信度、效度及反应度
J Gen Intern Med. 2022 Aug;37(10):2541-2547. doi: 10.1007/s11606-021-07307-1. Epub 2022 Jan 3.
本文引用的文献
1
A Society of General Internal Medicine Position Statement on the Internists' Role in Social Determinants of Health.普通内科医学协会关于内科医生在健康的社会决定因素中作用的立场声明。
J Gen Intern Med. 2020 Sep;35(9):2721-2727. doi: 10.1007/s11606-020-05934-8. Epub 2020 Jun 9.
2
Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare Beneficiaries.COPD 住院后启动肺康复治疗与 Medicare 受益人的 1 年生存率之间的关联。
JAMA. 2020 May 12;323(18):1813-1823. doi: 10.1001/jama.2020.4437.
3
Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.慢性阻塞性肺疾病的药物治疗。美国胸科学会临床实践指南。
Am J Respir Crit Care Med. 2020 May 1;201(9):e56-e69. doi: 10.1164/rccm.202003-0625ST.
4
Effectiveness of Tai Chi for health promotion for adults with health conditions: a scoping review of Meta-analyses.太极拳对患有健康问题的成年人促进健康的有效性：一项Meta分析的范围综述
Disabil Rehabil. 2021 Oct;43(21):2978-2989. doi: 10.1080/09638288.2020.1725916. Epub 2020 Feb 18.
5
Clinical course and management of idiopathic pulmonary fibrosis.特发性肺纤维化的临床病程与管理
Multidiscip Respir Med. 2019 Dec 2;14:35. doi: 10.1186/s40248-019-0197-0. eCollection 2019.
6
Diagnostic approach to chronic dyspnoea in adults.成人慢性呼吸困难的诊断方法。
J Thorac Dis. 2019 Oct;11(Suppl 17):S2117-S2128. doi: 10.21037/jtd.2019.10.53.
7
Effect of inhaler drug education on fatigue, dyspnea severity, and respiratory function tests in patients with COPD.吸入器药物教育对 COPD 患者疲劳、呼吸困难严重程度和呼吸功能测试的影响。
Patient Educ Couns. 2020 Apr;103(4):709-716. doi: 10.1016/j.pec.2019.11.003. Epub 2019 Nov 5.
8
Dyspnea in COPD: New Mechanistic Insights and Management Implications.COPD 患者呼吸困难：新的发病机制见解与管理意义。
Adv Ther. 2020 Jan;37(1):41-60. doi: 10.1007/s12325-019-01128-9. Epub 2019 Oct 30.
9
A Randomized, Double-Blind, Multisite, Pilot, Placebo-Controlled Trial of Regular, Low-Dose Morphine on Outcomes of Pulmonary Rehabilitation in COPD.一项关于常规低剂量吗啡对慢性阻塞性肺疾病患者肺康复结局影响的随机、双盲、多中心、试点、安慰剂对照试验。
J Pain Symptom Manage. 2019 Nov;58(5):e7-e9. doi: 10.1016/j.jpainsymman.2019.07.026. Epub 2019 Aug 9.
10
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights.间质性肺疾病慢性呼吸衰竭的管理：概述与临床见解。
Int J Med Sci. 2019 Jun 10;16(7):967-980. doi: 10.7150/ijms.32752. eCollection 2019.
Zotero 插件